中文 | English
Return
Total: 356 , 1/36
Show Home Prev Next End page: GO
Author:(Ke DU)

4.Application of extraocular muscle related indexes combined with serum Th1 cytokine levels in the diagnosis of thyroid associated ophthalmopathy

Jun DU ; Jiakai LIU ; Ke XU ; Jing LI ; Chunmei ZHOU ; Jin ZHU

International Eye Science 2025;25(12):2022-2027

5.High risk factors in images for infiltrating lung adenocarcinoma manifesting as peripheral ground-glass nodules

Jiangjiang LIU ; Xiaojun YU ; Haitao HUANG ; Shaomu CHEN ; Liangbin PAN ; Yu FENG ; Ke CHEN ; Guocai MAO ; Haitao MA

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(01):85-91

6.Study on the Analgesic Material Basis of Zhejiang Vinegar Corydalis Rhizoma Based on Chemometrics

LI Yafei ; ZHAO Mingling ; TANG Rui ; FANG Ke' ; er ; ZHANG Hair ; GE Weihong ; DU Weifeng

Chinese Journal of Modern Applied Pharmacy 2024;41(14):1892-1899

7.Cancer cell membrane-coated bacterial ghosts for highly efficient paclitaxel delivery against metastatic lung cancer.

Dandan LING ; Xueli JIA ; Ke WANG ; Qiucheng YAN ; Bochuan YUAN ; Lina DU ; Miao LI ; Yiguang JIN

Acta Pharmaceutica Sinica B 2024;14(1):365-377

8.Preliminary study of the transport and absorption mechanism of Astragalus polysaccharide-Ⅱ on M cells

Wan-wan LÜ ; Ke LI ; Shi-hong FENG ; Yu-wei WEN ; Xue-mei QIN ; Yu-guang DU ; Zhen-yu LI

Acta Pharmaceutica Sinica 2024;59(10):2820-2827

9.Study on the characteristic branch sites of oligosaccharides of Astragalus polysaccharide APS-Ⅱ enzymolysis based on high resolution mass spectrometry

Yu-chong LIU ; Hu-feng LI ; Ke LI ; Xue-mei QIN ; Yu-guang DU ; Zhen-yu LI

Acta Pharmaceutica Sinica 2024;59(7):2108-2116

10.Pharmacodynamic and Mechanism of Anti-influenza Effect of Jiawei Xiangru Oral Liquid

Wei LI ; Qing DU ; Dan CHEN ; Xiaoqing WANG ; Xiaolan LI ; Ke LI

Chinese Journal of Modern Applied Pharmacy 2024;41(7):927-938

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 356 , 1/36 Show Home Prev Next End page: GO